(Q35555146)

8 August 2017

title

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis (English)

1 reference

8 August 2017

Braun J

1

1 reference

8 August 2017

Brandt J

2

1 reference

8 August 2017

Listing J

3

1 reference

8 August 2017

Zink A

4

1 reference

8 August 2017

Alten R

5

1 reference

8 August 2017

Burmester G

6

1 reference

8 August 2017

Gromnica-Ihle E

7

1 reference

8 August 2017

Kellner H

8

1 reference

8 August 2017

Schneider M

9

1 reference

8 August 2017

Sörensen H

10

1 reference

8 August 2017

Zeidler H

11

1 reference

8 August 2017

Sieper J

12

1 reference

8 August 2017

language of work or name

English

0 references

publication date

23 September 2004

1 reference

Annals of the Rheumatic Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

64

1 reference

8 August 2017

issue

2

1 reference

8 August 2017

page(s)

229-234

1 reference

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

The MOS 36-ltem Short-Form Health Survey (SF-36)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755337

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

15 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15388511

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15388511

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/ARD.2004.025130

1 reference

8 August 2017

1 reference

8 August 2017

1 reference